Breaking News

Coeptis Acquires AI-Powered Marketing Platform

Creates new opportunities for growth while maintaining its primary focus on biopharmaceutical innovation.

Author Image

By: Charlie Sternberg

Associate Editor

Coeptis Therapeutics Holdings Inc., a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases, has executed a Binding Letter of Intent for the acquisition of NexGenAI Affiliates Network, a platform developed by NexGenAI Solutions Group and its affiliates that offers AI-powered marketing software and robotic process automation (RPA) capabilities.   By integrating AI-powered solutions and RPA tools, Coeptis not only enhances its operational eff...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters